We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
-11.3%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
AUM
$255M
AUM Growth
-$32.7M
Cap. Flow
+$5.14M
Cap. Flow %
2.02%
Top 10 Hldgs %
91.02%
Holding
41
New
5
Increased
11
Reduced
9
Closed
7

Top Sells

1
ENOV icon
Enovis
ENOV
+$8.9M
2
COST icon
Costco
COST
+$2.21M
3
INTC icon
Intel
INTC
+$1.36M
4
FTV icon
Fortive
FTV
+$1.22M
5
DHR icon
Danaher
DHR
+$976K

Sector Composition

1 Healthcare 30.96%
2 Technology 17.38%
3 Financials 13.04%
4 Consumer Staples 9.25%
5 Industrials 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGSH icon
1
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$54.4M 21.34%
923,861
+151,615
+20% +$8.94M
DHR icon
2
Danaher
DHR
$144B
$35.5M 13.93%
157,914
-4,238
-3% -$976K
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.06T
$33M 12.96%
120,985
+5,274
+5% +$1.65M
STAA icon
4
STAAR Surgical
STAA
$1.32B
$30.4M 11.93%
428,512
+40,655
+10% +$2.62M
FTV icon
5
Fortive
FTV
$18.8B
$23.9M 9.39%
583,763
-27,474
-4% -$1.22M
MNST icon
6
Monster Beverage
MNST
$95.4B
$14.3M 5.61%
308,524
+2,486
+0.8% +$108K
TDY icon
7
Teledyne Technologies
TDY
$29.4B
$12.6M 4.94%
33,557
+5,077
+18% +$2.12M
AXON
8
Axon Enterprise
AXON
$41.1B
$10.8M 4.22%
115,416
+7,606
+7% +$804K
COST icon
9
Costco
COST
$417B
$9.03M 3.54%
18,830
-4,365
-19% -$2.21M
LCTX icon
10
Lineage Cell Therapeutics
LCTX
$289M
$8.11M 3.18%
5,131,935
+125,750
+3% +$166K
INTC icon
11
Intel
INTC
$478B
$4.6M 1.81%
123,065
-31,500
-20% -$1.36M
ESAB icon
12
ESAB
ESAB
$5.58B
$2.56M 1.01%
+58,587
New +$2.83M
BE icon
13
Bloom Energy
BE
$61.1B
$2.51M 0.98%
152,100
+1,100
+0.7% +$20.1K
IMDX
14
Insight Molecular Diagnostics
IMDX
$153M
$2.33M 0.91%
129,469
+1,362
+1% +$31K
PLTR icon
15
Palantir
PLTR
$317B
$1.76M 0.69%
194,165
+41,100
+27% +$406K
MGY icon
16
Magnolia Oil & Gas
MGY
$5.04B
$1.58M 0.62%
+75,300
New +$1.88M
LFCR icon
17
Lifecore Biomedical
LFCR
$176M
$912K 0.36%
91,450
-30,000
-25% -$297K
AAPL icon
18
Apple
AAPL
$4.9T
$875K 0.34%
6,403
-100
-2% -$15.1K
ANIP icon
19
ANI Pharmaceuticals
ANIP
$1.8B
$712K 0.28%
24,000
AMZN icon
20
Amazon
AMZN
$2.66T
$559K 0.22%
5,260
+300
+6% +$37.5K
MSFT icon
21
Microsoft
MSFT
$2.93T
$535K 0.21%
2,085
KMI icon
22
Kinder Morgan
KMI
$71.9B
$520K 0.2%
31,000
-10,000
-24% -$187K
IVV icon
23
iShares Core S&P 500 ETF
IVV
$881B
$447K 0.18%
1,179
AMWL icon
24
American Well
AMWL
$221M
$427K 0.17%
4,946
-2,130
-30% -$159K
FDX icon
25
FedEx
FDX
$74.7B
$340K 0.13%
+1,500
New +$320K

Similar funds

Defender Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Defender Capital held 41 positions worth $255M, down 11% from $288M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Defender Capital's Q2 2022 filing shows 5 new, 11 increased, 9 reduced and 7 closed positions. Its largest new stake was ESAB: 58,587 shares worth $2.56M. The largest sale was Enovis, an estimated $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

  • Defender Capital's largest Q2 2022 buy was ESAB: 58,587 shares worth $2.56M.
  • Defender Capital added most to Vanguard Short-Term Treasury ETF in Q2 2022, an estimated $8.94M increase.
  • Defender Capital's biggest Q2 2022 reduction was Costco, cutting an estimated $2.21M.
  • Defender Capital fully exited Enovis in Q2 2022, selling an estimated $8.9M.
  • Defender Capital's ten largest holdings make up 91% of its $255M portfolio in Q2 2022.
  • Defender Capital opened 5 new positions and closed 7 in Q2 2022.
  • Defender Capital's portfolio value fell 11% quarter-over-quarter to $255M.

Based on Defender Capital's 13F filing for Q2 2022, filed 26 Jul 2022.